Boston Research & Management Inc Pfizer Inc Transaction History

Boston Research & Management Inc

$395 Million
Q2 2024

A detailed history of Boston Research & Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Boston Research & Management Inc holds 16,763 shares of PFE stock, worth $497,190. This represents 0.12% of its overall portfolio holdings.

Number of Shares

16,763

Previous 16,763 -0.0%

Holding current value

$497,190

Previous $465,000 0.86%

% of portfolio

0.12%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $190,174 - $247,015	-7,278 Reduced 30.27%	16,763 $482,000
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $7,549 - $8,734	209 Added 0.88%	24,041 $881,000
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $2,875 - $3,743	-73 Reduced 0.31%	23,832 $972,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $3,047 - $3,978	73 Added 0.31%	23,905 $1.22 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $23,552 - $34,912	-570 Reduced 2.34%	23,832 $1.41 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $13,388 - $17,024	-400 Reduced 1.61%	24,402 $898,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $134,302 - $157,567	4,230 Added 20.56%	24,802 $910,000
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $12,048 - $14,616	400 Added 1.98%	20,572 $672,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $88,829 - $107,744	-2,577 Reduced 11.33%	20,172 $888,000
Q2 2018 Jul 30, 2018	BUY	$32.98 - $35.16 $84,989 - $90,607	2,577 Added 12.78%	22,749 $825,000
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $26,608 - $28,232	-800 Reduced 3.81%	20,172 $730,000
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $650,132 - $716,193	20,972	20,972 $748,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.

Account

Boston Research & Management Inc Pfizer Inc Transaction History